CCLR325X2202: A Randomized, Subject and Investigator-Blind, Placebo Controlled Study of CLR325 in Chronic Stable Heart Failure Patients

Project: Research project

Project Details

StatusFinished
Effective start/end date10/1/15 → 8/31/19

Funding

  • Novartis Pharmaceuticals Corporation (CCLR325X2202)